Generics - Financial, Daiichi Sankyo


Current filters:

FinancialDaiichi Sankyo

Popular Filters

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements


In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Ranbaxy sales rocket 55%, net rises four-fold


Ranbaxy Laboratories (AB: BO), India's largest drugmaker, came in with a stompingly good set of financial…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Ranbaxy posts $586 million loss due to charges


India’s largest drugmaker Ranbaxy Laboratories (RAB: BO), which is 64% owned by Japan’s Daiichi…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Back to top